HCA Healthcare Inc (NYSE:HCA) Forecasted to Earn Q2 2019 Earnings of $2.39 Per Share

HCA Healthcare Inc (NYSE:HCA) – Equities research analysts at Svb Leerink cut their Q2 2019 earnings per share estimates for shares of HCA Healthcare in a report released on Tuesday, April 30th, Zacks Investment Research reports. Svb Leerink analyst A. Gupte now anticipates that the company will earn $2.39 per share for the quarter, down from their prior forecast of $2.49. Svb Leerink also issued estimates for HCA Healthcare’s Q3 2019 earnings at $2.33 EPS, Q4 2019 earnings at $2.81 EPS, FY2019 earnings at $10.49 EPS and FY2020 earnings at $12.59 EPS.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.31 by $0.66. HCA Healthcare had a negative return on equity of 112.65% and a net margin of 7.71%. The firm had revenue of $12.52 billion during the quarter, compared to analysts’ expectations of $12.34 billion. During the same period last year, the firm posted $3.18 EPS. The business’s revenue was up 9.6% on a year-over-year basis.

A number of other research firms have also recently weighed in on HCA. Barclays dropped their price target on HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating for the company in a report on Wednesday, April 17th. Raymond James raised HCA Healthcare from a “market perform” rating to an “outperform” rating and raised their price target for the company from $115.00 to $135.00 in a report on Tuesday, April 23rd. Oppenheimer raised their price target on HCA Healthcare from $142.00 to $150.00 and gave the company an “outperform” rating in a report on Wednesday, January 30th. ValuEngine cut HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, March 6th. Finally, Deutsche Bank increased their price objective on HCA Healthcare from $160.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, May 1st. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and nineteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $149.41.

HCA stock traded up $0.81 during midday trading on Thursday, reaching $123.51. 1,198,211 shares of the company’s stock traded hands, compared to its average volume of 1,809,590. HCA Healthcare has a 1-year low of $101.30 and a 1-year high of $147.42. The stock has a market capitalization of $42.17 billion, a price-to-earnings ratio of 12.64, a P/E/G ratio of 0.99 and a beta of 0.75.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Monday, June 3rd will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, May 31st. This represents a $1.60 annualized dividend and a dividend yield of 1.30%. HCA Healthcare’s dividend payout ratio is currently 16.38%.

In other news, insider Jon M. Foster sold 44,281 shares of the firm’s stock in a transaction on Friday, May 10th. The stock was sold at an average price of $122.28, for a total value of $5,414,680.68. Following the transaction, the insider now directly owns 96,052 shares in the company, valued at approximately $11,745,238.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.70% of the stock is owned by company insiders.

Several large investors have recently bought and sold shares of the company. Horizon Investments LLC bought a new position in shares of HCA Healthcare in the 1st quarter worth $206,000. Kore Private Wealth LLC bought a new position in HCA Healthcare during the first quarter worth about $33,000. Kiwi Wealth Investments Limited Partnership bought a new position in HCA Healthcare during the first quarter worth about $9,877,000. BlueCrest Capital Management Ltd bought a new position in HCA Healthcare during the first quarter worth about $554,000. Finally, HighTower Advisors LLC lifted its holdings in HCA Healthcare by 21.4% during the first quarter. HighTower Advisors LLC now owns 40,262 shares of the company’s stock worth $5,251,000 after acquiring an additional 7,097 shares in the last quarter. Institutional investors and hedge funds own 71.66% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: FAANG Stocks

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.